In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Intuitive Surgical Secures New Technologies

Executive Summary

The economic meltdown that drove many publicly traded share prices into the ground promised to spark a shopping spree for strategic investors looking to score inexpensive assets. The deals largely haven't materialized, but Intuitive Surgical., with more than $800 million in cash reserves and investments, is certainly beginning to nibble. Over the past six months, Intuitive has signed three technology-sharing agreements and bought the assets of a fourth in pursuit of new technologies to help feed future products to sell along side-or potentially inside-its da Vinci surgical systems.

You may also be interested in...



Robots In The Cath Lab -- Is This The Future Of PCI?

Robotic-driven technology has begun to transform surgery, but not without leaving some surgeons unimpressed. Now Corindus is trying to bring robots to the cath lab -- and this time physicians love the technology because it provides an ergonomically better experience and both enhances the procedure and reduces health problems.

Raising Robotics: An Interview With Intuitive's Lonnie Smith

The tremendous success of Intuitive Surgical over the past two decades seems clearly to argue that robotics is more than a techy's pipedream. Intuitive has already revolutionized at least one procedure - laparoscopic prostatectomy - and it figures to make significant progress in a range of others, in men's health, women's health, and cardiovascular surgery, to name just a few relevant clinical spaces. Even more impressive has been its success as a publicly traded company; for much of the middle years of this decade, Intuitive's stock was the strongest performer among all medical device public offerings. And perhaps most interesting: until recently, Intuitive was virtually the only robotics company to achieve any kind of success at all. In Vivo interviews Lonnie Smith, the CEO of the company for much of the 1990s and 2000s, to whom much of the credit should go.

New Directions for Robotic Surgery

Medical robotics has changed dramatically since the 1980s, when neurosurgeons first used a robot to precisely hold a fixture during brain surgery. Advances in computer image processing, surgical imaging technologies, techniques for registering surgical images, modeling, mechatronics, surgical simulation, and human-robot interaction have opened the door for emerging technologies that will have an increasing impact on growth in this market for many years to come.

Related Content

Topics

Related Companies

Related Deals

Latest Headlines
See All
UsernamePublicRestriction

Register

IV003325

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel